BOK Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$551K Sell
5,131
-1,940
-27% -$208K 0.01% 543
2025
Q1
$713K Sell
7,071
-386
-5% -$38.9K 0.01% 483
2024
Q4
$708K Buy
7,457
+84
+1% +$7.97K 0.01% 488
2024
Q3
$618K Buy
7,373
+4,308
+141% +$361K 0.01% 521
2024
Q2
$236K Buy
3,065
+377
+14% +$29K ﹤0.01% 740
2024
Q1
$183K Sell
2,688
-434
-14% -$29.6K ﹤0.01% 730
2023
Q4
$180K Buy
3,122
+876
+39% +$50.6K ﹤0.01% 674
2023
Q3
$115K Sell
2,246
-14,568
-87% -$746K ﹤0.01% 692
2023
Q2
$909K Sell
16,814
-378
-2% -$20.4K 0.02% 474
2023
Q1
$860K Sell
17,192
-17,840
-51% -$893K 0.02% 482
2022
Q4
$1.62M Buy
35,032
+2,490
+8% +$115K 0.03% 405
2022
Q3
$1.26M Sell
32,542
-9,908
-23% -$384K 0.03% 453
2022
Q2
$1.58M Sell
42,450
-588
-1% -$21.9K 0.03% 425
2022
Q1
$1.91M Buy
43,038
+4,581
+12% +$203K 0.03% 427
2021
Q4
$1.63M Sell
38,457
-6,573
-15% -$279K 0.03% 460
2021
Q3
$1.95M Buy
+45,030
New +$1.95M 0.03% 401
2021
Q1
$905K Sell
23,407
-14,222
-38% -$550K 0.02% 575
2020
Q4
$1.35M Buy
37,629
+18,642
+98% +$670K 0.03% 450
2020
Q3
$725K Buy
18,987
+176
+0.9% +$6.72K 0.02% 534
2020
Q2
$661K Sell
18,811
-1,553
-8% -$54.6K 0.02% 549
2020
Q1
$664K Buy
20,364
+484
+2% +$15.8K 0.02% 506
2019
Q4
$899K Sell
19,880
-9,523
-32% -$431K 0.02% 537
2019
Q3
$1.2M Buy
29,403
+12,082
+70% +$491K 0.03% 452
2019
Q2
$744K Buy
17,321
+9,204
+113% +$395K 0.02% 561
2019
Q1
$311K Buy
8,117
+800
+11% +$30.7K 0.01% 773
2018
Q4
$259K Buy
7,317
+1,338
+22% +$47.4K 0.01% 766
2018
Q3
$231K Buy
+5,979
New +$231K 0.01% 850